Life Sciences
Regenerix LLC
Year
2023
Regenerix is developing therapies for neurodegenerative disorders utilizing next-generation RIPK1/RIPK3 inhibitors.
Company Status
Active
U of A Inventors
May Khanna
Vijay Gokhale
Jonathan Lares Sanchez
College
College of Medicine - Tucson, BIO5 Institute, College of Pharmacy